Literature DB >> 32277896

Redefining non-alcoholic fatty liver disease: what's in a name?

.   

Abstract

Entities:  

Year:  2020        PMID： 32277896     DOI： 10.1016/S2468-1253(20)30091-1

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


× No keyword cloud information.
  5 in total

Review 1.  Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?

Authors:  Jalpa Devi; Aimun Raees; Amna Subhan Butt
Journal:  World J Hepatol       Date:  2022-01-27

2.  Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice?

Authors:  Coskun Ozer Demirtas; Yusuf Yilmaz
Journal:  Hepatol Forum       Date:  2020-09-21

Review 3.  Role of Leptin in Non-Alcoholic Fatty Liver Disease.

Authors:  Carlos Jiménez-Cortegana; Alba García-Galey; Malika Tami; Pilar Del Pino; Isabel Carmona; Soledad López; Gonzalo Alba; Víctor Sánchez-Margalet
Journal:  Biomedicines       Date:  2021-06-30

Review 4.  The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update.

Authors:  Reem Abou Assi; Ibrahim M Abdulbaqi; Chan Siok Yee
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-04

5.  Quality of Life in Adults with Metabolic Dysfunction-Associated Fatty Liver Disease.

Authors:  Tae-In Hwang; A-Lum Han
Journal:  Int J Environ Res Public Health       Date:  2021-12-13       Impact factor: 3.390
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.